173 related articles for article (PubMed ID: 22877565)
21. Apolipoprotein M: progress in understanding its regulation and metabolic functions.
Christoffersen C; Dahlbäck B; Nielsen LB
Scand J Clin Lab Invest; 2006; 66(7):631-7. PubMed ID: 17101555
[TBL] [Abstract][Full Text] [Related]
22. Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Tao Q; Zhang Y
Lipids Health Dis; 2016 Sep; 15(1):158. PubMed ID: 27633510
[TBL] [Abstract][Full Text] [Related]
23. The miR-573/apoM/Bcl2A1-dependent signal transduction pathway is essential for hepatocyte apoptosis and hepatocarcinogenesis.
Hu YW; Chen ZP; Hu XM; Zhao JY; Huang JL; Ma X; Li SF; Qiu YR; Wu XJ; Sha YH; Gao JJ; Wang YC; Zheng L; Wang Q
Apoptosis; 2015 Oct; 20(10):1321-37. PubMed ID: 26201458
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol exerts a biphasic effect on apolipoprotein M.
Kurano M; Hara M; Nojiri T; Ikeda H; Tsukamoto K; Yatomi Y
Br J Pharmacol; 2016 Jan; 173(1):222-33. PubMed ID: 26445217
[TBL] [Abstract][Full Text] [Related]
25. Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M.
Yang L; Zhao S
Int J Mol Med; 2012 Mar; 29(3):510-4. PubMed ID: 22160096
[TBL] [Abstract][Full Text] [Related]
26. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
[TBL] [Abstract][Full Text] [Related]
27. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.
Christoffersen C; Obinata H; Kumaraswamy SB; Galvani S; Ahnström J; Sevvana M; Egerer-Sieber C; Muller YA; Hla T; Nielsen LB; Dahlbäck B
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9613-8. PubMed ID: 21606363
[TBL] [Abstract][Full Text] [Related]
28. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes.
Kumaraswamy SB; Linder A; Åkesson P; Dahlbäck B
Crit Care; 2012 Dec; 16(2):R60. PubMed ID: 22512779
[TBL] [Abstract][Full Text] [Related]
29. Correlation analysis between ApoM gene-promoter polymorphisms and coronary heart disease.
Zhang Y; Huang LZ; Yang QL; Liu Y; Zhou X
Cardiovasc J Afr; 2016; 27(4):228-237. PubMed ID: 27841911
[TBL] [Abstract][Full Text] [Related]
30. The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
Park YJ; Yoo SA; Lee JH; Chung YJ; Cho CS; Kim W-
Clin Exp Rheumatol; 2013; 31(2):180-8. PubMed ID: 23190940
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1.
Mulya A; Seo J; Brown AL; Gebre AK; Boudyguina E; Shelness GS; Parks JS
J Lipid Res; 2010 Mar; 51(3):514-24. PubMed ID: 19767535
[TBL] [Abstract][Full Text] [Related]
32. Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells.
Luo G; Hurtig M; Zhang X; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2005 May; 1734(2):198-202. PubMed ID: 15904876
[TBL] [Abstract][Full Text] [Related]
33. The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles.
Christoffersen C; Benn M; Christensen PM; Gordts PLSM; Roebroek AJM; Frikke-Schmidt R; Tybjaerg-Hansen A; Dahlbäck B; Nielsen LB
J Lipid Res; 2012 Oct; 53(10):2198-2204. PubMed ID: 22826357
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.
Elsøe S; Ahnström J; Christoffersen C; Hoofnagle AN; Plomgaard P; Heinecke JW; Binder CJ; Björkbacka H; Dahlbäck B; Nielsen LB
Atherosclerosis; 2012 Mar; 221(1):91-7. PubMed ID: 22204862
[TBL] [Abstract][Full Text] [Related]
35. Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway.
Jiang B; Zhang X; Di D; Luo G; Shi Y; Zhang J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2015 Sep; 14():110. PubMed ID: 26377577
[TBL] [Abstract][Full Text] [Related]
36. [Reduced expression and secretion of apolipoprotein M in fat-fed, streptozotocin-diabetic rats is partially reversed by an artificial ligand of PPARγ].
Qu X; Zhao S; Gao J; Hu M; Dong L; Zhang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):796-801. PubMed ID: 22954914
[TBL] [Abstract][Full Text] [Related]
37. The orphan nuclear receptor Nur77 regulates hepatic cholesterol metabolism through the suppression of LDLR and HMGCR expression.
Zhang P; Hu Y; Yang J; Zheng L; Wang Q
Mol Med Rep; 2012 Jun; 5(6):1541-7. PubMed ID: 22470048
[TBL] [Abstract][Full Text] [Related]
38. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
[TBL] [Abstract][Full Text] [Related]
39. Orphan Nuclear Receptor Nur77 Inhibits Angiotensin II-Induced Vascular Remodeling via Downregulation of β-Catenin.
Cui M; Cai Z; Chu S; Sun Z; Wang X; Hu L; Yi J; Shen L; He B
Hypertension; 2016 Jan; 67(1):153-62. PubMed ID: 26597820
[TBL] [Abstract][Full Text] [Related]
40. Intralipid decreases apolipoprotein M levels and insulin sensitivity in rats.
Zheng L; Feng Y; Shi Y; Zhang J; Mu Q; Qin L; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Luo G; Xu N
PLoS One; 2014; 9(8):e105681. PubMed ID: 25144649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
